Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro

Author:          

Publisher: Spandidos Publications

ISSN: 1792-0981

Source: Experimental and Therapeutic Medicine, Vol.2, Iss.6, 2011-01, pp. : 1171-1176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content